Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 17 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-174.04 Insider Own3.41% Shs Outstand2.87M Perf Week4.76%
Market Cap3.16M Forward P/E- EPS next Y- Insider Trans306.54% Shs Float2.77M Perf Month-60.57%
Income-17.46M PEG- EPS next Q- Inst Own0.60% Short Float2.93% Perf Quarter-89.45%
Sales0.00M P/S- EPS this Y- Inst Trans3.27% Short Ratio0.05 Perf Half Y-96.95%
Book/sh-20.76 P/B- EPS next Y- ROA-384.86% Short Interest0.08M Perf Year-98.97%
Cash/sh0.29 P/C3.85 EPS next 5Y- ROE-1018.78% 52W Range1.00 - 137.50 Perf YTD-98.27%
Dividend Est.- P/FCF- EPS past 5Y17.98% ROI- 52W High-99.20% Beta1.06
Dividend TTM- Quick Ratio0.26 Sales past 5Y0.00% Gross Margin- 52W Low10.00% ATR (14)0.66
Dividend Ex-Date- Current Ratio0.26 EPS Y/Y TTM70.10% Oper. Margin0.00% RSI (14)26.31 Volatility17.75% 25.22%
Employees5 Debt/Eq- Sales Y/Y TTM- Profit Margin- Recom3.00 Target Price1500.00
Option/ShortNo / No LT Debt/Eq- EPS Q/Q84.27% Payout- Rel Volume0.14 Prev Close1.11
Sales Surprise- EPS Surprise- Sales Q/Q- Earnings- Avg Volume1.63M Price1.10
SMA20-33.25% SMA50-81.09% SMA200-97.12% Trades Volume248,556 Change-0.90%
Date Action Analyst Rating Change Price Target Change
Dec-28-20Downgrade Ladenburg Thalmann Buy → Neutral
Aug-24-20Initiated Ladenburg Thalmann Buy $11
Jul-16-24 09:15AM
Jul-11-24 07:29AM
Jul-03-24 11:10AM
Jun-26-24 08:00AM
Jun-14-24 03:11PM
08:00AM Loading…
Jun-10-24 08:00AM
Jun-03-24 08:05AM
May-20-24 08:30AM
May-16-24 11:53AM
Apr-23-24 09:00AM
Apr-22-24 10:15AM
Apr-01-24 11:52PM
09:00PM Loading…
Jan-29-24 09:00PM
Jan-18-24 08:45AM
Jan-17-24 08:45AM
Dec-18-23 08:35AM
Dec-06-23 09:00AM
Nov-22-23 09:05AM
Nov-16-23 10:00AM
Nov-15-23 08:00AM
Oct-19-23 09:05AM
Oct-18-23 10:00AM
Oct-16-23 09:00AM
Oct-11-23 08:45AM
Sep-07-23 08:45AM
Sep-05-23 08:45AM
Aug-14-23 08:35AM
07:35AM Loading…
Aug-03-23 08:15AM
Jul-27-23 09:05AM
Jul-05-23 08:45AM
Jun-14-23 09:05AM
May-25-23 09:05AM
May-15-23 08:35AM
May-08-23 08:45AM
May-03-23 08:45AM
Apr-27-23 08:45AM
Apr-17-23 06:54AM
Apr-10-23 08:45AM
Apr-06-23 09:05AM
Apr-03-23 08:05AM
Mar-29-23 09:05AM
Mar-13-23 07:05AM
Mar-09-23 09:05AM
Feb-07-23 08:45AM
Jan-12-23 08:45AM
Jan-11-23 01:00PM
Jan-05-23 09:05AM
Jan-03-23 02:28PM
Dec-08-22 09:08AM
Dec-05-22 08:05AM
Nov-30-22 10:00PM
Nov-28-22 04:53PM
Nov-15-22 01:09PM
Nov-14-22 04:05PM
Nov-02-22 08:45AM
Oct-10-22 09:00AM
Oct-07-22 08:00AM
Sep-28-22 09:05AM
Sep-23-22 09:00AM
Sep-07-22 08:45AM
Aug-15-22 08:05AM
Jul-25-22 08:05AM
Jun-23-22 08:35AM
Jun-08-22 08:35AM
May-24-22 07:00AM
May-19-22 03:57PM
May-18-22 08:35AM
May-16-22 08:05AM
Apr-28-22 08:35AM
Apr-13-22 10:45AM
Apr-12-22 08:35AM
Apr-06-22 08:35AM
Apr-05-22 08:35AM
Mar-23-22 08:35AM
Mar-09-22 09:20AM
Mar-03-22 08:35AM
Feb-01-22 07:30AM
Jan-20-22 09:40AM
Jan-12-22 10:35AM
Jan-10-22 05:00PM
Jan-07-22 08:05AM
Jan-06-22 07:00AM
Dec-31-21 01:50PM
Dec-21-21 10:00AM
Dec-02-21 08:35AM
Nov-16-21 08:00AM
Nov-04-21 02:30PM
Oct-11-21 08:00AM
Sep-30-21 12:25PM
Aug-15-21 03:41AM
Aug-13-21 08:05AM
Jul-12-21 07:30AM
CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Climaco John MChief Executive OfficerFeb 01 '24Buy0.30166,66650,000215,676Feb 06 10:27 AM
Downs ChristopherChief Financial OfficerFeb 01 '24Buy0.3066,66620,000103,438Feb 06 10:27 AM
Evans Carl AnthonyDirectorFeb 01 '24Buy0.3033,33310,00033,458Feb 06 10:27 AM
Gumulka JerzyDirectorFeb 01 '24Buy0.3033,33310,00043,006Feb 06 10:28 AM
Downs ChristopherChief Financial OfficerAug 22 '23Buy1.2727,00034,17736,772Aug 23 08:00 AM
Climaco John MChief Executive OfficerAug 16 '23Buy1.802,7504,94449,010Aug 16 04:01 PM